• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于国际标准化比值(PT-INR)和年龄的模型可作为评估2019冠状病毒病(SARS-CoV-2)感染患者死亡风险的一种有前景的预测指标。

A model based on PT-INR and age serves as a promising predictor for evaluating mortality risk in patients with SARS-CoV-2 infection.

作者信息

Xu Yongjie, Tang Minjie, Guo Zhaopei, Lin Yanping, Guo Hongyan, Fang Fengling, Lin Lin, Shi Yue, Lai Lu, Pan Yan, Tang Xiangjun, You Weiquan, Li Zishun, Song Jialin, Wang Liang, Cai Weidong, Fu Ya

机构信息

Department of Laboratory Medicine, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.

Department of Laboratory Medicine, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.

出版信息

Front Cell Infect Microbiol. 2025 Apr 3;15:1499154. doi: 10.3389/fcimb.2025.1499154. eCollection 2025.

DOI:10.3389/fcimb.2025.1499154
PMID:40248368
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12003402/
Abstract

COVID-19 caused by the coronavirus SARS-CoV-2 has resulted in a global pandemic. Considering some patients with COVID-19 rapidly develop respiratory distress and hypoxemia, early assessment of the prognosis for COVID-19 patients is important, yet there is currently a lack of research on a comprehensive multi-marker approach for disease prognosis assessment. Here, we utilized a large sample of hospitalized individuals with COVID-19 to systematically compare the clinical characteristics at admission and developed a nomogram model that was used to predict prognosis. In all cases, those with pneumonia, older age, and higher PT-INR had a poor prognosis. Besides, pneumonia patients with older age and higher PT-INR also had a poor prognosis. A nomogram model incorporating presence of pneumonia, age and PT-INR could evaluate the prognosis in all patients with SARS-CoV-2 infections well, while a nomogram model incorporating age and PT-INR could evaluate the prognosis in those with pneumonia well. Together, our study establishes a prognostic prediction model that aids in the timely identification of patients with poor prognosis and helps facilitate the improvement of treatment strategies in clinical practice in the future.

摘要

由冠状病毒SARS-CoV-2引起的COVID-19已导致全球大流行。鉴于一些COVID-19患者会迅速发展为呼吸窘迫和低氧血症,对COVID-19患者的预后进行早期评估很重要,但目前缺乏关于用于疾病预后评估的综合多标志物方法的研究。在此,我们利用大量住院的COVID-19患者样本系统地比较了入院时的临床特征,并开发了一种用于预测预后的列线图模型。在所有病例中,患有肺炎、年龄较大且PT-INR较高的患者预后较差。此外,年龄较大且PT-INR较高的肺炎患者预后也较差。纳入肺炎、年龄和PT-INR的列线图模型可以很好地评估所有SARS-CoV-2感染患者的预后,而纳入年龄和PT-INR的列线图模型可以很好地评估肺炎患者的预后。总之,我们的研究建立了一个预后预测模型,有助于及时识别预后不良的患者,并有助于促进未来临床实践中治疗策略的改进。

相似文献

1
A model based on PT-INR and age serves as a promising predictor for evaluating mortality risk in patients with SARS-CoV-2 infection.基于国际标准化比值(PT-INR)和年龄的模型可作为评估2019冠状病毒病(SARS-CoV-2)感染患者死亡风险的一种有前景的预测指标。
Front Cell Infect Microbiol. 2025 Apr 3;15:1499154. doi: 10.3389/fcimb.2025.1499154. eCollection 2025.
2
Development and validation of a prognostic nomogram for predicting in-hospital mortality of COVID-19: a multicenter retrospective cohort study of 4086 cases in China.开发和验证一种预测 COVID-19 住院患者死亡率的预后列线图:一项中国多中心回顾性队列研究 4086 例。
Aging (Albany NY). 2021 Feb 9;13(3):3176-3189. doi: 10.18632/aging.202605.
3
Development and validation of nomogram models for severe and fatal COVID-19.开发和验证严重和致命 COVID-19 的列线图模型。
Sci Rep. 2024 Nov 25;14(1):29146. doi: 10.1038/s41598-024-80310-8.
4
A nomogramic model based on clinical and laboratory parameters at admission for predicting the survival of COVID-19 patients.基于入院时临床和实验室参数的列线图模型预测 COVID-19 患者的生存。
BMC Infect Dis. 2020 Nov 30;20(1):899. doi: 10.1186/s12879-020-05614-2.
5
Prolonged prothrombin time as an early prognostic indicator of severe acute respiratory distress syndrome in patients with COVID-19 related pneumonia.凝血酶原时间延长作为新型冠状病毒肺炎相关肺炎患者严重急性呼吸窘迫综合征的早期预后指标
Curr Med Res Opin. 2021 Jan;37(1):21-25. doi: 10.1080/03007995.2020.1853510. Epub 2020 Dec 7.
6
An easy-to-use nomogram for predicting in-hospital mortality risk in COVID-19: a retrospective cohort study in a university hospital.用于预测 COVID-19 院内死亡率风险的易于使用的列线图:大学附属医院的回顾性队列研究。
BMC Infect Dis. 2021 Feb 5;21(1):148. doi: 10.1186/s12879-021-05845-x.
7
Exploration of prognostic factors for critical COVID-19 patients using a nomogram model.利用列线图模型探索危重症 COVID-19 患者的预后因素。
Sci Rep. 2021 Apr 14;11(1):8192. doi: 10.1038/s41598-021-87373-x.
8
An online tool for predicting the prognosis of cancer patients with SARS-CoV-2 infection: a multi-center study.一种用于预测 SARS-CoV-2 感染癌症患者预后的在线工具:一项多中心研究。
J Cancer Res Clin Oncol. 2021 Apr;147(4):1247-1257. doi: 10.1007/s00432-020-03420-6. Epub 2020 Oct 11.
9
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
10
ANDC: an early warning score to predict mortality risk for patients with Coronavirus Disease 2019.ANDC:一种预测2019冠状病毒病患者死亡风险的早期预警评分
J Transl Med. 2020 Aug 31;18(1):328. doi: 10.1186/s12967-020-02505-7.

本文引用的文献

1
The mortality of hospitalized patients with COVID-19 and non-cirrhotic chronic liver disease: a retrospective multi-center study.COVID-19 合并非肝硬化慢性肝病住院患者的死亡率:一项回顾性多中心研究。
PeerJ. 2023 Dec 4;11:e16582. doi: 10.7717/peerj.16582. eCollection 2023.
2
Investigating Biomarkers for COVID-19 Morbidity and Mortality.探讨 COVID-19 发病率和死亡率的生物标志物。
Curr Top Med Chem. 2023;23(13):1196-1210. doi: 10.2174/1568026623666230222094517.
3
Hematologic Evaluation of Children with COVID-19 Infection: Mortality Biomarkers.
儿童 COVID-19 感染的血液学评估:死亡率生物标志物。
Clin Lab. 2022 Apr 1;68(4). doi: 10.7754/Clin.Lab.2021.210746.
4
National early warning score (NEWS) 2 predicts hospital mortality from COVID-19 patients.国家早期预警评分(NEWS)2可预测新冠肺炎患者的医院死亡率。
Ann Med Surg (Lond). 2022 Apr;76:103462. doi: 10.1016/j.amsu.2022.103462. Epub 2022 Mar 8.
5
One-on-one comparison between qCSI and NEWS scores for mortality risk assessment in patients with COVID-19.qCSI 评分与 NEWS 评分对 COVID-19 患者死亡风险评估的一对一比较。
Ann Med. 2022 Dec;54(1):646-654. doi: 10.1080/07853890.2022.2042590.
6
Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality.新冠病毒感染发病率、严重程度和死亡率的风险和保护因素。
Clin Rev Allergy Immunol. 2023 Feb;64(1):90-107. doi: 10.1007/s12016-022-08921-5. Epub 2022 Jan 19.
7
COVID-19 and immunothrombosis: Pathophysiology and therapeutic implications.COVID-19 与免疫血栓形成:病理生理学与治疗意义。
Crit Rev Oncol Hematol. 2021 Dec;168:103529. doi: 10.1016/j.critrevonc.2021.103529. Epub 2021 Nov 17.
8
Audio Interview: A Look at Covid-19 Prevention and Care in 2020.音频访谈:2020年新冠疫情的预防与护理观察
N Engl J Med. 2020 Dec 31;383(27):e147. doi: 10.1056/NEJMe2036225.
9
Age-specific mortality and immunity patterns of SARS-CoV-2.SARS-CoV-2 的年龄特异性死亡率和免疫模式。
Nature. 2021 Feb;590(7844):140-145. doi: 10.1038/s41586-020-2918-0. Epub 2020 Nov 2.
10
Interleukin-6 in Covid-19: A systematic review and meta-analysis.白细胞介素 6 在新冠病毒感染中的作用:系统评价和荟萃分析。
Rev Med Virol. 2020 Nov;30(6):1-9. doi: 10.1002/rmv.2141. Epub 2020 Aug 26.